Insulin and IL-4 sensitivity was restored to the IL-3-dependent 32D cell line by expression of insulin receptor substrate-1 (IRS-I). the principal phosphotyrosine substrate of the insulin receptor. IL-4 treatment of 32D cells overexpressing IRS-I causes prompt tyrosine phosphorylation of IRS- I. Transfection of truncation mutants of the human IL-4 receptor into 32D.IRS-1 cells demonstrated that the region between amino acids 437 and 557 is critical for IL-4 signaling. This region of the IL-4 receptor contains the I4R motif, found in the insulin and IGF-1 receptors. Mutation of Y497 to F yielded receptors that failed to cause IRS-1 phosphorylation in response to human IL-4 when expressed in 32D.IRS-1 cells. Most cell lines expressing Y497F also failed to proliferate in response to human IL-4. furthermore. a GST-fusion protein containing the I4R motif bound IRS-I. a tyrosine kinase(s) and other unidentified phosphoproteins with molecular sizes of 140. 80 and 55 kDa. These results indicate that the central tyrosine of the I4R motif is critical for IL-4-mediated signal transduction in 32D cells. The SH2 domain of GRB-2 specifically binds to a tryptic peptide containing tyrosine 895 of tyrosine phosphorylated IRS-I. Substitution of tyrosine 895 with phenylalanine (IRS-1F895) prevents formation of the IRS-1/GRB-2 complex in vitro and in vivo. Insulin-stimulated mitogenesis in 32D cells requires expression of the insulin receptor and either IRS-I or IRS-1F895. suggesting that the IRS-1/GRB-2 complex is not essential for this response. In contrast. insulin stimulation of Shc tyrosine phosphorylation. formation of the Shc/GRB-2 complex and activation of mitogen activated protein (MAP) kinase required expression of the insulin receptor. but was independent of IRS-I and unaffected by expression of IRS-1F895. Therefore. IRS-I. but not an IRS-1/GRB-2 complex. is required for insulin-stimulated mitogenesis in 32D cells. whereas Shc/GRB-2 may be sufficient for insulin stimulation of MAP kinase through the SOS/p2I ras pathway. However. insulin is not able to mediate an efficient mitogenic response in 32D cells overexpressing only the insulin receptor. suggesting that activation of the SOS/p2I ras pathway may be necessary but not sufficient for eliciting proliferation in this stem.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Intramural Research (Z01)
Project #
1Z01CP005164-14
Application #
3752622
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
14
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Division of Cancer Epidemiology and Genetics
Department
Type
DUNS #
City
State
Country
United States
Zip Code